Buphenyl Therapy for Byler's Disease
Information source: University of Pittsburgh
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Byler Disease
Intervention: Buphenyl (Drug)
Phase: N/A
Status: No longer available
Sponsored by: University of Pittsburgh
Summary
This is a single patient compassionate use protocol to determine whether Buphenyl
(4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.
Clinical Details
Official title: Compassionate Use of BuphenylŪ in the Treatment of Byler's Disease
Study design: N/A
Eligibility
Minimum age: 1 Year.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Byler Disease
- Cholestasis unresponsive to pharmacologic therapy
Exclusion Criteria:
- Allergy/Hypersensitivity to Buphenyl
Locations and Contacts
Additional Information
Last updated: February 4, 2013
|